Generic Sweden AB (STO:GENI)
Sweden · Delayed Price · Currency is SEK 40.15
+0.55 (1.39%)
Aug 14, 2026, 5:22 PM CET
Generic Sweden AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 189.13 | 184.76 | 177.32 | 143.07 | 127.94 | 114.8 |
Other Revenue | - | - | 0.03 | - | - | -0 |
| 189.13 | 184.76 | 177.35 | 143.07 | 127.94 | 114.8 | |
Revenue Growth | 4.98% | 4.18% | 23.96% | 11.82% | 11.45% | 40.38% |
Cost of Revenue | 137.83 | 134.53 | 132.63 | 104.32 | 92.4 | 82.87 |
Gross Profit | 51.29 | 50.23 | 44.72 | 38.75 | 35.54 | 31.93 |
Selling, General & Admin | 11.55 | 10.66 | 10.43 | 9.36 | 8.67 | 7.69 |
Other Operating Expenses | 0 | 0 | - | 0.01 | - | - |
Operating Expenses | 12.64 | 11.66 | 11.41 | 10.15 | 9.78 | 9.09 |
Operating Income | 38.66 | 38.57 | 33.32 | 28.61 | 25.76 | 22.84 |
Interest Expense | -0.01 | -0.01 | -0.02 | -0 | -0.05 | -0.03 |
Interest & Investment Income | 0.56 | 0.56 | 1.05 | 0.78 | 0.05 | 0.04 |
Other Non Operating Income (Expenses) | 0 | 0 | -0 | -0 | - | - |
Pretax Income | 39.21 | 39.13 | 34.35 | 29.38 | 25.77 | 22.85 |
Income Tax Expense | 8.14 | 8.09 | 7.1 | 6.07 | 5.32 | 4.72 |
Earnings From Continuing Operations | 31.08 | 31.04 | 27.25 | 23.31 | 20.45 | 18.13 |
Net Income | 31.08 | 31.04 | 27.25 | 23.31 | 20.45 | 18.13 |
Net Income to Common | 31.08 | 31.04 | 27.25 | 23.31 | 20.45 | 18.13 |
Net Income Growth | 5.69% | 13.89% | 16.90% | 14.01% | 12.79% | 67.19% |
Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 | 12 |
Shares Change | 0.34% | 0.34% | 0.05% | -0.39% | -0.12% | 0.09% |
EPS (Basic) | 2.52 | 2.52 | 2.22 | 1.90 | 1.66 | 1.47 |
EPS (Diluted) | 2.52 | 2.52 | 2.22 | 1.90 | 1.66 | 1.47 |
EPS Growth | 5.34% | 13.51% | 16.84% | 14.46% | 12.93% | 67.05% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 30.57 | 38.98 | 23.8 | 20.72 | 15.92 | 19.09 |
Free Cash Flow Per Share | 2.48 | 3.17 | 1.94 | 1.69 | 1.29 | 1.55 |
Dividend Per Share | 1.750 | 1.750 | 1.600 | 1.500 | 1.250 | 1.000 |
Dividend Growth | 9.38% | 9.38% | 6.67% | 20.00% | 25.00% | 25.00% |
Gross Margin | 27.12% | 27.19% | 25.22% | 27.09% | 27.78% | 27.82% |
Operating Margin | 20.44% | 20.88% | 18.79% | 19.99% | 20.14% | 19.89% |
Profit Margin | 16.43% | 16.80% | 15.37% | 16.29% | 15.98% | 15.79% |
Free Cash Flow Margin | 16.17% | 21.10% | 13.42% | 14.48% | 12.44% | 16.63% |
EBITDA | 39.51 | 39.34 | 34.04 | 29.31 | 26.74 | 24.15 |
EBITDA Margin | 20.89% | 21.29% | 19.19% | 20.49% | 20.90% | 21.03% |
D&A For EBITDA | 0.85 | 0.76 | 0.72 | 0.7 | 0.98 | 1.31 |
EBIT | 38.66 | 38.57 | 33.32 | 28.61 | 25.76 | 22.84 |
EBIT Margin | 20.44% | 20.88% | 18.79% | 19.99% | 20.14% | 19.89% |
Effective Tax Rate | 20.75% | 20.68% | 20.67% | 20.66% | 20.66% | 20.67% |
Revenue as Reported | 189.13 | 184.76 | 177.35 | 143.07 | 127.94 | 114.8 |